纳米载体生产技术和方法的进步,以提高药物的向输送:全面的审查
Atish Kumar S Mundada1, Lokesh P Kothari1, Kuldeep Vinchurkar2
1Department of Pharmaceutics, SNJBs SSDJ College of Pharmacy, Chandwad, Nashik, Maharashtra 423101, India.
Current drug delivery
|August 4, 2025
概括
纳米技术提供使用纳米载体 (1-100纳米) 的先进药物输送,以提高疗效和减少副作用. 在生产和表面工程方面的创新使得有针对性的,可控的治疗干预措施成为可能.
科学领域:
- 纳米医学是一种纳米医学.
- 材料科学 材料科学 材料科学
- 制药科学 制药科学
背景情况:
- 纳米技术已经彻底改变了药物输送系统.
- 纳米载体比传统方法具有优势,在1-100纳米范围内运行.
- 关键的纳米载体包括脂质体,树状体和聚合物微粒.
研究的目的:
- 审查生产各种纳米载体的关键技术和方法.
- 突出纳米载体在复杂的药物输送系统中的作用.
- 强调纳米载体在有针对性和受控的治疗干预中的潜力.
主要方法:
- 探索生产技术,如班哈姆程序,溶剂注射和微流体通道.
- 对微流体学和纳米沉等创新方法进行讨论,以获得可扩展性和一致性.
- 审查表面工程的进步,包括连接体结合和刺激响应涂层.
主要成果:
- 纳米载体增强药物的疗效,减少副作用,提高生物可用性.
- 先进的方法提高了纳米载体的可扩展性和一致性.
- 表面工程有助于改进向和控制药物释放.
结论:
- 纳米载体对于先进的药物输送至关重要,提供精度和调节释放.
- 生物相容和可生物降解的纳米材料扩大了临床实用性,特别是在瘤学,神经学和基因治疗中.
- 纳米载体证明了针对性,高效和可控的治疗干预的多功能性.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Drug Delivery Systems: Different Types
418
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
418
Modified-Release Drug Delivery Systems: Overview
243
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
243
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
Oral Drug Delivery Systems: Introduction
284
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
284


